Heterogeneous Responses of Axillary Lymph Node Metastases to Neoadjuvant Chemotherapy are Common and Depend on Breast Cancer Subtype.

MLA

Glaeser, Antonia, et al. “Heterogeneous Responses of Axillary Lymph Node Metastases to Neoadjuvant Chemotherapy Are Common and Depend on Breast Cancer Subtype.” Annals of Surgical Oncology, vol. 26, no. 13, Dec. 2019, pp. 4381–89. EBSCOhost, https://doi.org/10.1245/s10434-019-07915-6.

APA

Glaeser, A., Sinn, H.-P., Garcia-Etienne, C., Riedel, F., Hug, S., Schaefgen, B., Golatta, M., Hennigs, A., Feisst, M., Sohn, C., & Heil, J. (2019). Heterogeneous Responses of Axillary Lymph Node Metastases to Neoadjuvant Chemotherapy are Common and Depend on Breast Cancer Subtype. Annals of Surgical Oncology, 26(13), 4381–4389. https://doi.org/10.1245/s10434-019-07915-6

Chicago

Glaeser, Antonia, Hans-Peter Sinn, Carlos Garcia-Etienne, Fabian Riedel, Sarah Hug, Benedikt Schaefgen, Michael Golatta, et al. 2019. “Heterogeneous Responses of Axillary Lymph Node Metastases to Neoadjuvant Chemotherapy Are Common and Depend on Breast Cancer Subtype.” Annals of Surgical Oncology 26 (13): 4381–89. doi:10.1245/s10434-019-07915-6.